Viewing Study NCT06298968


Ignite Creation Date: 2025-12-24 @ 5:53 PM
Ignite Modification Date: 2025-12-27 @ 10:57 PM
Study NCT ID: NCT06298968
Status: RECRUITING
Last Update Posted: 2024-07-03
First Post: 2024-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma
Sponsor: Nanfang Hospital, Southern Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module